SCHEMBL5230929

SCHEMBL5230929

O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1ncc[nH]1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCB P05771 9/20 0.72
PRKCA P17252 5/20 0.72
CDK4 P11802 3/20 0.72
CCND1 P24385 3/20 0.72
CDK2 P24941 3/20 0.72
PRKCH P24723 3/20 0.72
PRKCE Q02156 3/20 0.72
PRKCQ Q04759 3/20 0.72
PRKCD Q05655 3/20 0.72
CCNE2 O96020 2/20 0.72
PRKACA P17612 2/20 0.72
PRKACG P22612 2/20 0.72
PRKACB P22694 2/20 0.72
CCNE1 P24864 2/20 0.72
CAMK2D Q13557 2/20 0.72
ABL1 P00519 2/20 0.72
SIRT2 Q8IXJ6 2/20 0.72
PRKD3 O94806 1/20 0.72
CCNB2 O95067 1/20 0.72
PRKCG P05129 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ro-316233 SCHEMBL624896 0.85 PRKCB (1.00) PRKCBPRKCACDK4CCND1CDK2
Ro-316233 SCHEMBL29373011 0.85 PRKCB (1.00) PRKCBPRKCACDK4CCND1CDK2
SCHEMBL1325544 0.82 HSD17B10 (0.54) PRKCBPRKCACDK4CCND1CDK2
SCHEMBL13596802 0.81 PRKCB (0.72) PRKCBPRKCACDK4CCND1CDK2
SCHEMBL3148490 0.78 PRKCB (0.84) PRKCBPRKCACDK4CCND1CDK2
SCHEMBL5328391 0.75 PRKCB (0.72) PRKCBPRKCACDK4CCND1CDK2
SCHEMBL13917970 0.75 PRKCB (0.78) PRKCBPRKCACDK4CCND1CDK2
SCHEMBL8167180 0.75 PRKCB (0.78) PRKCBPRKCACDK4CCND1CDK2
SCHEMBL3908534 0.75 PRKCB (0.78) PRKCBPRKCACDK4CCND1CDK2
SCHEMBL6823304 0.75 PRKCB (0.78) PRKCBPRKCACDK4CCND1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070068-B2 GRANULATIMIDE DERIVATIVES FOR USE IN CANCER TREATMENT UNIV BRITISH COLUMBIA (CA) 2007-01-17 EP disclosed
EP-1070068-B1 GRANULATIMIDE DERIVATIVES FOR USE IN CANCER TREATMENT UNIV BRITISH COLUMBIA (CA) 2003-10-08 EP disclosed
US-6291447-B1 INHIBITING THE G2 CHECKPOINT IN A CELL THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2001-09-18 US disclosed
EP-1070068-A1 GRANULATIMIDE DERIVATIVES FOR USE IN CANCER TREATMENT THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2001-01-24 EP disclosed
WO-1999047522-A1 GRANULATIMIDE DERIVATIVES FOR USE IN CANCER TREATMENT THE UNIVERSITY OF BRITISH COLUMBIA (CA) 1999-09-23 WO disclosed